RxDoctor Payments Data

Seema Gupta

Psychiatry · Dallas, TXNPI 1164717716

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,298 of the $1,532 with a category attached, or 84.7%. Biohaven Pharmaceutical Holding Company Ltd. accounts for 87.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $1,335 and has fallen 92.9% since, to $95 in 2025.

$1,532in general payments, 2019–2025

Across 12 payments — averaging $127.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceutical Holding Company Ltd.$1K
  • AbbVie$103
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$95
$1,194,336in research payments, 2019–2025

Across 151 payments — averaging $7909.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$710K
  • Axsome Therapeutics, Inc.$317K
  • Janssen Research & Development, LLC$141K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$26K

What the payments were for

  • Travel & lodging$1,29885%
  • Food & beverage$23415%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,532 in reported general payments places this provider in the 75th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Other psychiatry in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →